o2h co-work Labs Launches the World’s First Influencer Biotech Bootcamp...

2 years ago

Cambridge, UK, 24 Sept 2021: o2h co-work labs, a business unit of o2h Group, are absolutely delighted to launch the first ever influencer biotech bootcamp covering representatives from the quintet influencer community that are the creative forces driving biotech. The event is going to be held at the newly renovated the old Mill house at the Mill SciTech Park, where o2h co-work labs is building a community of creators covering life-science, technology and green innovation.

Looking far beyond the ‘start-up’ skills the bootcamp endeavours to bring together a dozen influencers covering the quintet of (1) Scientists & Techies (2) Biotech CXO’s (3) Big Pharma, (4) Academia/Profs & Govt (5) Incubators & Seed/VC’s looking to share live grassroots experiences and who have demonstrated a hard stake in shaping the future of life science. The o2h co-work labs are looking for the dozen to have a fascination to learn from the candid hard experiences and deep expertise of others across the quintet.

Prashant Shah, CEO of o2h co-work Labs, said: “Biotech is a truly collaborative endeavour and we wanted to create a bootcamp to share grassroot experiences across the quintet of actors that are shaping biotech in Britain. The dozen attendees have been coined as the biotech dirty dozen as they will be proven in some small way in getting their hands dirty to help British biotech to flourish. We are delighted to mark the beginning of o2h co-work labs with this bootcamp to coincide with the completion of the renovation of Hauxton House, Mill SciTech Park which shall be its permanent home”

The event, which is invite only, shall be organised over two days on Tuesday 5th and Wednesday 6th October from 9am to 2.30pm. The content will include an eclectic pedagogy of high intensity expert subject tours, masterclasses, personal stories, workshops, Q&A’s and debates covering the eight zones of (A) Business & Economy, (B) Biology & Chemistry, (C) Strategy, Operations & Team, (D) AI & Tech, (E) Customers & Investors (F) Deals & Exits (G) Innovation & Creativity (H) Cambridge & World Domination.

Attendees amongst others will include Shaun Grady, Senior Vice President, Business Development Operations at AstraZeneca; Tim Guilliams, Co-founder and CEO of Healx; Michael Anstey, Partner at Cambridge Innovation Capital; Iain Thomas, Head of Life Sciences at Cambridge Enterprise; Myriam Ouberai, CEO and Founder of Spirea; Hannah Sore, Founder and CEO of PharmEnable; Catherine Beech OBE, CEO of Exonate, Nektarios (Aris) Oraiopoulos, Lecturer at Cambridge Judge Business School; Chris Lowe, Professor at University of Cambridge; Tej Panesar, Investment Director - Life Sciences at British Patient Capital; Dr Sally Ann Forsyth OBE, Chief Executive Officer at Stevenage Bioscience Catalyst; Tamsin Berry, former Director of the UK government’s Office for Life Sciences..

Notes to Editors

About o2h co-work labs:

o2h co-work labs operates the 2.76 acre heritage Hauxton Mill site in the UK, with plans to develop it into The Mill SciTech Park. The first phase of the renovation including high speciation biology labs is complete and planning permission is underway for the second phase including the renovation of the Mill taking a spot alongside some of the most buzzing cultures for creativity and innovation from around the world.

The attendant community includes the quintet of CEO/CXO’s, big business, the venture community, academics/govt and the scientists/techies. o2h co-work labs offers friendly and flexible post pandemic arrangements.

For more information or to sign up as an associate member and join the community please see - https://o2h.com/co-work-labs/

About o2h Group:

o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life. o2h group triages investment, incubation and execution and is organised into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h therapeutics, o2h technology, o2h co-work, and o2h community.

For more information, please see – www.o2h.com

Media Contact:

Prashant Shah
CEO of o2h co-work Labs
prashant@o2h.com

Attached Media

About o2h Ventures Limited

o2h Ventures Limited has launched the o2h Therapeutics and AI fund which is the first S/EIS fund in the UK solely focused on early stage biotech therapeutics and related AI opportunities. The geographic scope shall be UK wide including Oxford and London but will target the growing Cambridge biotech cluster. The Fund is structured to be S/EIS compliant providing tax breaks for UK taxpayers. The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years. o2h operate from their proprietary 2.7 acre The Mill SciTech Park where they are developing a unique model for incubating small life science companies. For further information: www.o2h.com/ventures

Press Contacts

Ajit Singh

Marketing and PR

ajit@o2h.com